ライフサイエンスコーパス: resect

1 plored (BR: 49%, LA: 51%) and 110 (78%) were resected.

2 cers and results in many benign masses being resected.

3 an incremental loss in lifetime as >25 were resected.

4 maximized when an optimum range of nodes is resected.

5 edian of 3 (range: 1-5) contiguous ribs were resected.

6 e taken almost 3 years after the tumors were resected.

7 tspots in 4 patients at sites where SNs were resected.

8 ly integrate within the MRX-Sae2 ensemble to resect 5'-terminated DNA.

9 During ePLND 22 additional SNs were resected (7 in the hybrid tracer group and 15 in the "fr

10 During ePLND, 22 additional SNs were resected (7 in the hybrid-tracer group and 15 in the fre

11 stage I/II at diagnosis (89%) and completely resected (87%).

12 Tumors were resected after 1 wk of tumor growth, and sham surgery wa

13 ss the prognostic performance of ART in PDAC resected after NAT.

14 g was observed compared with control spleens resected after trauma (P < 0.001).

15 Independent predictors of OS in resected ampullary cancer were N-stage, perineural invas

16 gery (IGS) and photodynamic therapy (PDT) to resect and ablate cancer cells.

17 modest gain in lifetime up to 25 lymph nodes resected and an incremental loss in lifetime as >25 were

18 MRE11 nuclease removal of SPO11, the DSB is resected and loaded with DMC1 filaments for homolog inva

19 , 95% CI 1.2-1.3, respectively) in primarily resected and neoadjuvantly treated patients.

20 robust gain in lifetime up to 30 lymph nodes resected and then an incremental loss in lifetime.

21 ifically, the failure to properly replicate, resect, and/or form appropriate telomeric structures dri

22 olyps 1 to 20 mm are frequently incompletely resected, and that risk increases for polyps 10 mm or la

23 With the optical Resect-and-Discard strategy, these polyps are then remov

24 ation inadequate; 8% as detected lesion, not resected; and 7% as incomplete resection of previously o

25 For comparison, corresponding surgically-resected aortic wall tissue samples were obtained and su

26 Resected arterial segments included the coeliac trunk (5

27 from biofilms dislodged from the surfaces of resected arthroplasties (sonicate fluid).

28 We assume that the primary tumor is resected at a given size and study the earliest time at

29 ease control in patients with hepatoblastoma resected at diagnosis.

30 Patients with primary chemotherapy resected at the Massachusetts General Hospital between 2

31 n 100 early-stage NSCLC tumors that had been resected before systemic therapy.

32 es of the adenocarcinoma spectrum surgically resected between 2006-2010.

33 s manifesting as subsolid nodules surgically resected between January 2005 and May 2018, with three o

34 analyzed 20 resected pancreatic IOPNs and 3 resected biliary IOPNs using a broad RNA-based targeted

35 ew of the literature on adjuvant therapy for resected biliary tract cancer and provide recommended ca

36 I randomized controlled trial, patients with resected biliary tract cancer should be offered adjuvant

37 an improve overall survival in patients with resected biliary tract cancer when used as adjuvant chem

38 herapy, and (3) survival differences between resected BR/LA patients who received neoadjuvant FOLFIRI

39 Our TNT experience in resected BR/LA PDAC revealed high negative margin rates

40 k of relapse versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma in the p

41 brain irradiation to the surgical cavity of resected brain metastases results in low rates of local

42 institutions in the USA and Canada with one resected brain metastasis and a resection cavity less th

43 RNA sequencing was performed on eight resected brain metastasis tissue samples and revealed B-

44 outcomes compared with WBRT in patients with resected brain metastasis.

45 Ex vivo autoradiography was performed on resected brain slices and subsequently stained with cres

46 We report the diagnoses made on the basis of resected brain specimens from 9523 patients who underwen

47 of human microglia isolated from surgically resected brain tissue ex vivo and after transition to an

48 re were significant correlations between the resected brain tissue volume and the ganglion cell layer

49 ncerous, benign, and transitional regions of resected breast tissue from six patients undergoing mast

50 20 cases of primary breast cancer tissue and resected BrM (10 estrogen receptor [ER]-negative and 10

51 ent-matched primary breast cancer tissue and resected BrM.

52 There was no benefit of adjuvant GEMOX in resected BTC despite adequate tolerance and delivery of

53 3)-serine into purine nucleotides in freshly resected cancerous and matched noncancerous lung tissues

54 Resected carotid plaques were retrieved for somatostatin

55 From the Institutional Pan-NEN database, 587 resected cases from 1990 to 2015 were extracted.

56 However, resecting them is not superior to resecting channels with highest rates of HFOs.

57 Patients and Methods Adult patients with resected, clinical stage I or II adenocarcinoma of the h

58 this population-based cohort of early-stage resected colon cancer, disease laterality was not associ

59 ts were compared with epileptogenic zone and resected cortex for congruence assessment and validated

60 with the presumed epileptogenic zone and the resected cortex were 75.0% and 78.8%, respectively, whic

61 y oscillation sources corresponding with the resected cortex, had the best sensitivity of 78.0%, posi

62 lation sources were spatially congruent with resected cortex, patients had an odds ratio of 5.67 and

63 tudies showing increased NEAT1 expression in resected cortical tissue from high spiking regions of pa

64 Resected cPanNENs (1995-2017) from 16 institutions world

65 In this international cohort study of 263 resected cPanNENs from 16 institutions worldwide, a preo

66 Overall, 263 resected cPanNENs were included, among which 177 (63.5%)

67 he lymphangiogenic signature was assessed in resected CRLM specimens by Rt-QPCR.

68 Patients with resected CRLM treated at MSKCC with and without adjuvant

69 E1609 was a phase III trial in patients with resected cutaneous melanoma (American Joint Committee on

70 onal trial, eligible patients had surgically resected cutaneous melanoma in the following categories:

71 s to characterize an international cohort of resected cystic pancreatic neuroendocrine neoplasms (cPa

72 ve sheath tumour, non-metastatic and grossly resected dermatofibrosarcoma protuberans, undifferentiat

73 ere resected (IQR = 1-3), and number of ribs resected did not correlate with margin status (p = 0.36)

74 mplex function, PTEN-deficient cells fail to resect DNA double-strand breaks efficiently after irradi

75 or efficient PCNA loading and restoration of resected DNA As a result, srs2Delta mutants are deficien

76 coordinated with downstream re-synthesis of resected DNA We show that Rad51 inhibits recruitment of

77 pose a model in which during re-synthesis of resected DNA, the replication machinery must catch up wi

78 e that initiates homologous recombination by resecting DNA double-strand breaks (DSBs).

79 A1-deficient cell to form RAD51 filaments at resected DSBs in a PALB2- and BRCA2-dependent manner, an

80 Here, we define structures of resected DSBs in mouse spermatocytes genome-wide at nucl

81 eta MMEJ of long ssDNA overhangs which model resected DSBs.

82 n BRCA1-null cells restores PALB2 accrual at resected DSBs.

83 an-NENs have been increasingly diagnosed and resected during the last 3 decades, revealing reliable p

84 All gross tumor was resected during the procedure.

85 Adjuvant chemotherapy for resected early-stage non-small-cell lung cancer (NSCLC)

86 red as an adjuvant therapy for patients with resected early-stage NSCLC.

87 verall survival for patients with surgically resected early-stage NSCLC.

88 ray analysis was performed on 13 early-stage resected EGFR-mutant-positive NSCLC across 59 sectors to

89 apse: those with non-metastatic incompletely resected embryonal rhabdomyosarcoma occurring at unfavou

90 year, whereas positive surgical margins and resected extrahepatic disease determined prognosis there

91 n-related variables (ie, surgical margin and resected extrahepatic disease) determined prognosis ther

92 f BRAF and KRAS mutations, R1 margin status, resected extrahepatic disease, patient age, primary tumo

93 roup; however, there were more patients with resected extrahepatic metastases in the no-HAI group.

94 Resected FOLFIRINOX patients have survival that appears

95 al parameters fail to predict survival among resected FOLFIRINOX patients.

96 Analysis of obstructive ureteric tissue resected from children with congenital intrinsic uretero

97 y, 30 randomly selected cases of lung cancer resected from January 1, 2008, through December 31, 2009

98 BCSC) from individual triple-negative tumors resected from patients after neoadjuvant chemotherapy.

99 tein 43 (GAP-43) expression in brain samples resected from patients with cortical dysplasia (CD), whi

100 The percentage of resected FRs, ripples, or spikes in pre-ECoG did not pre

101 er, the effect of MMRD and MSI in curatively resected gastric cancer treated with perioperative chemo

102 lar matrix (ECM) remodeling in the partially resected glands.

103 ed blood loss was 260 mL (+/-100), mean (SD) resected graft weight was 592 g (+/-174).

104 ar DFS was only 14.4% in the nonanatomically resected group, versus 46.4% in the anatomically resecte

105 cted group, versus 46.4% in the anatomically resected group.

106 An international, multicenter cohort of R0 resected HCC patients were categorized by MC status at p

107 lectin-9 levels prognostically differentiate resected HCC patients, independently of their intra-tumo

108 and circulating Galectin-9 in patients with resected HCC, and to compare their prognostic significan

109 ation of RPS15A expression in 110 surgically resected HCCs and matched tumor-adjacent normal tissues

110 Bacterial growth in cultures of resected heart valves of patients with infective endocar

111 l (OS) in patients with localized completely resected high-risk ccRCC.

112 cacious adjuvant treatment for patients with resected high-risk melanoma, with a safety profile that

113 In resected high-risk stage III melanoma, pembrolizumab adj

114 embrolizumab versus placebo in patients with resected high-risk stage III melanoma.

115 .43; p = 0.003) and increased number of ribs resected (HR 1.78; p = 0.02).

116 mouse, or following antagonism of NaV 1.7 in resected human appendix stimulated by noxious distending

117 zing datasets containing images from freshly resected human brain cancer and from a silica phantom ac

118 cute, ex vivo treatment of fresh, surgically resected human colorectal tumour biopsies as a novel pre

119 ctionation of beta8(high) cells from freshly resected human GBM samples also reveals a requirement fo

120 his study investigates the use of surgically resected human lobes as an alternative and novel model f

121 ILP of surgically resected human lobes is a feasible and promising method.

122 was also examined in a subset of surgically resected human lung adenocarcinomas by multispectral ima

123 Acini were collected from C57BL/6 mice and resected human pancreata and were cultured.

124 TM somatic mutations have been identified in resected human pancreatic tumors.

125 ls, fibroblasts, and bulk cells from freshly resected human primary non-small-cell lung tumors.

126 ased data on patients with stage I to II PaC resected in 2003 to 2015 from the US Surveillance, Epide

127 = 473), the clipped TLN was intraoperatively resected in 329 of 423 patients (77.8%, 95% confidence i

128 The MHV was resected in 6 patients, always sparing segments 4i and 5

129 dsDNA breaks (DSBs) are resected in a 5'->3' direction, generating single-strand

130 ghest rates of ripples and fast ripples were resected in a similar proportion.

131 layer 2/3 (L2/3) in human neocortical tissue resected in deep-brain surgery, and in mice as control.

132 identify genomic alterations associated with resected indolent and aggressive early lung ADCs.Methods

133 bservation (OBS) in patients with surgically resected intermediate-risk melanoma.

134 Detailed in situ analyses of resected intestine for specific cell type markers and VZ

135 al Hospital (MGH) databases were queried for resected IPMN (2000-2015).

136 ines should have increased the percentage of resected IPMN with high-risk disease.

137 449 consecutive patients with resected IPMNs from 1995-2018 were included to the study

138 A median of 2 ribs were resected (IQR = 1-3), and number of ribs resected did no

139 es of late extraocular relapse of previously resected iris melanoma, without concurrent intraocular r

140 of late extraocular relapse from previously resected iris melanoma.

141 h late subconjunctival relapse of previously resected iris melanoma.

142 ion The use of adjuvant CRT in patients with resected LAHNC with SM negative and no ECE is common.

143 Results Among patients with resected LAHNC with SM negative and no ECE, 47% received

144 ate significant differences in OS of 331 non-resected LAPC patients (P = 0.134).

145 rence rate mostly presenting as difficult to resect lesions.

146 seems acceptable given the complexity of the resected lesions.

147 Ten surgically resected lobes were perfused in acellular and normotherm

148 tem were validated using 1,647 patients with resected localized high-grade or locally advanced diseas

149 nt chemoradiotherapy (CRT) for patients with resected locally advanced head and neck cancer (LAHNC) w

150 perform multi-region exome sequencing of 116 resected lung nodules including AAH (n = 22), AIS (n = 2

151 ned using primary AEC2 (pAEC2) isolated from resected lung tissue.

152 It was assayed ex vivo in resected lung tissues collected from a dozen of patients

153 ne expression profiling on a large sample of resected lung tissues from subjects with severe COPD.

154 ortality (P > 0.05), nor the total number of resected lymph nodes (P > 0.05), nor with R0 resection r

155 day on 30-day mortality, the total number of resected lymph nodes, and R0 resection rates was evaluat

156 luding the 30-day mortality, total number of resected lymph nodes, and R0 resection rates.

157 (177 ex vivo biopsy samples from surgically resected masses were obtained from 49 patients and 55 in

158 preoperative risk factors for malignancy in resected MCNs and to assess outcomes of MCN-associated a

159 ct investigation for both tumor-bearing and -resected mice relative to surgical controls.

160 the respective tissues of tumor-bearing and -resected mice.

161 and fast ripples, first source channels were resected more often that the rest of the network channel

162 the RecBCD and AddAB clades of bacterial DSB-resecting motor nucleases.

163 During surgery, resected nodes were labeled to identify their nodal leve

164 VB) could predict poor long-term survival in resected non-small cell lung cancer (NSCLC) patients.

165 y (CRT) for locally advanced or incompletely resected non-small-cell lung cancer (NSCLC), it remains

166 ned treatment-naive patients with completely resected non-small-cell lung cancer who received postope

167 iterature, investigating adjuvant therapy in resected non-small-cell lung cancers.

168 cology (ASCO) adjuvant therapy guideline for resected non-small-cell lung cancers.

169 an independent risk factor for TFS and OS in resected NSCLC patients.

170 umab to adjuvant chemotherapy in early-stage resected NSCLC.

171 in 23 consecutive stage I-IIIA patients with resected NSCLC.

172 RPA renders a partially resected or palindromic DNA structure susceptible to MRX

173 examination inadequate; detected lesion, not resected; or likely incomplete resection of previously i

174 Data from resected oral surgical specimens show that the DeepDOF m

175 trends analysis revealed that the number of resected Pan-NENs constantly increased, while the size (

176 Among the 587 resected Pan-NENs, 75% were nonfunctioning tumors, and 5

177 Most patients diagnosed with resected pancreatic adenocarcinoma (PDAC) survive less t

178 mmendation 4.1 states that all patients with resected pancreatic adenocarcinoma who did not receive p

179 Patients with resected pancreatic cancer could be categorized accordin

180 Recommendations All patients with resected pancreatic cancer who did not receive preoperat

181 early disease-free survival in patients with resected pancreatic cancer.

182 es in predicting recurrence in patients with resected pancreatic cancer.

183 ne compared with gemcitabine monotherapy for resected pancreatic cancer.

184 5-fluorouracil/folinic acid in patients with resected pancreatic cancer.

185 e monotherapy in 730 evaluable patients with resected pancreatic ductal adenocarcinoma.

186 15,237 patients with clinical stage I or II resected pancreatic head adenocarcinoma.

187 val benefit compared with UR in early-stage, resected pancreatic head adenocarcinoma.

188 We analyzed 20 resected pancreatic IOPNs and 3 resected biliary IOPNs u

189 high-grade dysplasia is present in 14.9% of resected pancreatic MCNs for which risks include male se

190 s recurrence-free survival for patients with resected PanNETs.

191 a significant survival benefit in completely resected, pathologically node-negative distal esophageal

192 lioblastoma organoids (GBOs) from surgically resected patient tumor tissue using a chemically defined

193 neoadjuvant FOLFIRINOX compared with upfront resected patients (DFS: 29.1 vs 13.7, P < 0.001; OS: 37.

194 er in pN0 versus pN1 patients in the upfront resected patients (median 16 mo pN0 vs. 10 mo pN1 P < 0.

195 Resected patients had better performance status, smaller

196 Resected patients had lower preoperative CA 19-9 levels

197 We analysed 603 R0 resected patients to assess whether NLR, PLR and PC corr

198 The difference remained significant when non-resected patients were matched for time of neoadjuvant t

199 In both neoadjuvantly treated and primarily resected patients, high SII was significantly associated

200 of first recurrence or metastasis in upfront resected patients, nor in neoadjuvant-treated patients.

201 Among resected patients, preoperative CA 19-9 >100 U/mL and >8

202 all FOLFIRINOX patients and 37.7 months for resected patients.

203 received neoadjuvant FOLFIRINOX and upfront resected patients.

204 Tumor histology from 177 resected PDAC patients with follow-up data was subclassi

205 o evaluate recurrence patterns of surgically resected PDAC patients with negative (pN0) or positive (

206 We performed a retrospective cohort study of resected PDAC, using cases collected between 2008 and 20

207 In a large cohort of patients with resected PDAC, we show that increasing uPA mRNA expressi

208 djuvant chemotherapy improves survival after resected PDAC.

209 quencing with linked reads on longitudinally resected pGBM samples.

210 m hypersensitivity was also observed in tail-resected pigs at either two or four months following sur

211 Whole-exome sequencing of 159 prospectively resected pituitary adenomas showed that somatic copy num

212 lypectomy sites or assessments of margins of resected polyps.

213 We compared the percentage of resected pre-EEG events, time to recurrence, and the dif

214 hematoxylin and eosin-stained section of the resected prostate per patient was digitized and computat

215 We collected 31 resected PSC tumors and obtained CaC and SaC by laser ca

216 fore offering it to patients with completely resected pT2-4aN0M0 esophageal adenocarcinoma.

217 ) on long-term survival of 180 patients with resected pT3 tumors and without neoadjuvant therapy was

218 In radically resected (R0) specimens 19.8% (27/136) had a pCR (ypT0N0

219 terventions on small (< 20 mm), difficult to resect recurrent / residual colorectal neoplastic lesion

220 With respect to sites where SNs were resected, remaining hotspots may have been caused by res

221 e rate of SLNB correlates with the number of resected sentinel lymph nodes (SLNs), our primary end po

222 ssion of two tumors, which were subsequently resected; she has no evidence of disease 3 years after t

223 Overall, 75.9% of the intraoperatively resected SNs in the hybrid tracer group and 51.8% of the

224 Overall, 75.9% of the intraoperatively resected SNs in the hybrid-tracer group and 51.8% of the

225 ectroscopy to assess the entire margins of a resected specimen within clinically feasible time.

226 ypT1aN0 were seen in a limited number of R0 resected specimens (19.8% and 7.3%, respectively), where

227 RNA-sequencing of 90 resected specimens and unsupervised classification revea

228 TATATE activity with immunohistochemistry in resected specimens.

229 Our study enrolled 231 patients with resected stage 0-III CRC, identified at 5 tertiary care

230 therapy is not recommended for patients with resected stage I or II disease.

231 ective cohort study of 218,186 patients with resected stage I to III colon cancer in the National Can

232 ded a 25% random sample of all patients with resected stage I to III disease.

233 his open-label phase II trial, patients with resected stage IA to IIIA (7(th) edition of the American

234 ance status of 0 or 1 and who had completely resected stage IB (>/=4 cm) to IIIA (defined by the Amer

235 Patients with resected stage II-III melanoma have approximately a 35%

236 y duration apply to patients with completely resected stage III colon cancer who are being offered ad

237 Patients with resected stage III colon cancers were randomized to adju

238 -free survival than placebo in patients with resected stage III melanoma with BRAF V600E or V600K mut

239 f a phase 3 trial involving patients who had resected stage III melanoma with BRAF V600E or V600K mut

240 We randomly assigned 870 patients who had resected stage III melanoma with BRAF V600E or V600K mut

241 inib as adjuvant treatment for patients with resected stage III melanoma with BRAF(V600E) or BRAF(V60

242 -infiltrating lymphocytes from patients with resected stage III melanoma.

243 s associated with the disease-free status of resected stage III MMel patients after adjuvant ipilimum

244 A total of 1,873 women with incompletely resected stage III to IV disease were randomly assigned

245 rolizumab should be offered to patients with resected stage IIIA/B/C/D BRAF wild-type cutaneous melan

246 Patients aged 15 years or older with resected stage IIIB-C or IV melanoma and an Eastern Coop

247 e-free survival benefit versus ipilimumab in resected stage IIIB-C or IV melanoma indicating a long-t

248 ind, phase 3 adjuvant trial in patients with resected stage IIIB-C or stage IV melanoma, showed signi

249 inib would improve outcomes in patients with resected, stage III melanoma with BRAF V600 mutations.

250 ndomly assigned 870 patients with completely resected, stage III melanoma with BRAF V600E or V600K mu

251 In the phase 3 COMBI-AD study, patients with resected, stage III melanoma with BRAF(V600E) or BRAF(V6

252 equisite of additional surgery after locally resected T1 CRC is dependent on the risk of LNM.

253 on, and relevant data pertaining to the root-resected teeth performed from January 1990 to September

254 rate expression of these genes in surgically resected tenosynovium from CTS patients.

255 ication forks encounter G-quadruplexes, EXO1 resects the nascent DNA proximal to these structures to

256 tiates when helicases and nucleases process (resect) the free DNA ends to expose single-stranded DNA

257 However, resecting them is not superior to resecting channels wit

258 eans for a comprehensive analysis of live or resected thick human skin tissue.

259 eptor 5 (mGluR5) is consistently observed in resected tissue from patients with epilepsy and is equal

260 Colonic biopsies and resected tissue from patients with IBD (n = 62) and pati

261 oscopes have a limited depth-of-field (DOF), resected tissue is either frozen or preserved with chemi

262 Microscopic evaluation of resected tissue plays a central role in the surgical man

263 ool to provide histological information from resected tissue specimens in resource-limited settings.

264 diagnostic features across highly irregular resected tissue surfaces without serial refocusing.

265 lamp recordings of VENs from neurosurgically-resected tissue that show distinctive intrinsic membrane

266 cope to quickly image large areas of freshly resected tissue to provide histologic-quality images of

267 sions can be achieved in vivo and ex vivo on resected tissues without the need for specific biomarker

268 (HCC) have been successfully generated from resected tissues, no reliable methods have been reported

269 The resected TL volume and the volume of resected TL PET hypometabolism (TLH) were calculated fro

270 The resected TL volume and the volume of resected TL PET hyp

271 lity metrics are linked to the number of LNs resected to determine subsequent treatment and prognosis

272 r pathway in baker's yeast, these breaks are resected to form 3' single-strand tails that participate

273 the 5'-terminated DNA strands must first be resected to produce 3' overhangs.

274 ion, 5'-terminated DNA strands must first be resected to reveal 3'-overhangs.

275 lation of proliferation and migration of non-resected tumor cells, and provide a strategy to prevent

276 Using freshly resected tumor tissue, we describe an optimized ex vivo

277 ration and modulation of the PI3K pathway in resected tumor tissue.

278 rresponding histopathologic specimens of the resected tumor.

279 A comparative CyTOF analysis of resected-tumor samples from GBM-patients and mouse GBM-t

280 ganoids can be derived efficiently from both resected tumors and biopsies and cultured and passaged f

281 ermore, using PDX models of colon cancer and resected tumors from colon cancer patients, our data dem

282 MR) based metabolomic analysis of surgically resected tumors from forty five pituitary tumor patients

283 Yet, due to the scarcity of resected tumors treated in situ with radiotherapy, there

284 All resected tumors were derived from routine debulking surg

285 Using live time-lapse imaging of primary resected tumors, we discover that tumor-derived oRG-like

286 of these tumours but analysis of surgically resected tumour tissue allows a more extensive set of me

287 free survival in patients with incompletely resected tumours who received chemotherapy across CNS920

288 a dynamic (18)F-FDG lymphography, to then be resected under Cerenkov imaging guidance.

289 (guided by the radioisotope) and ultimately resected under real-time optical guidance (fluorescent d

290 djuvant sunitinib or sorafenib vs placebo in resected unfavorable renal cell carcinoma [RCC]), the la

291 ensity score with patients whose tumors were resected upfront.

292 etime predicted for each regional lymph node resected used quantile survival random forest methodolog

293 The rectum and mesorectum were resected using open instruments for rectal dissection (i

294 , Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis.

295 the study period, the percentage of BD-IPMN resected with >=1 high-risk feature increased (52% pre-G

296 lled; 223 patients with biliary tract cancer resected with curative intent were randomly assigned to

297 he 15-year study period, the rate of BD-IPMN resected with high-risk radiographic features increased;

298 These regions are then resected with the hope that the individual is rendered s

299 benign neoplasms and indolent cancers being resected without clear benefit.

300 patients), although the latter was commonly resected without postoperative deficits on the Stroop te